The global urinalysis market size is expected to reach USD 3.07 billion by 2030, expanding at a CAGR of 4.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU).

Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.

Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.

Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level. This product was developed with a help of UN-Series of Sysmex's and FlexLab TM track of Inpeco’s urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.

Urinalysis Market Report Highlights

• Based on product, the consumables segment held the largest share market in 2022 due to wider usage of dipsticks due to their efficiency coupled with lost costs
• Based on application, the disease screening segment accounted for the largest segment, owing to the increasing prevalence of target diseases such as UTI, kidney disease, and liver disease, along with the rising application of urinalysis for screening of these diseases
• On the basis of end-use, the clinical laboratories segment dominated the market in 2022 owing to higher patient footfall in clinical laboratories for urine testing for disease diagnosis
• Home care segment is expected to witness significant growth over the forecast period owing to increasing investment for the development of home-based urine testing kits for disease diagnosis
• North America segment dominated the market in 2022 due to favorable reimbursement policies, rising incidence of UTI, well-established healthcare infrastructure, and supportive regulatory reforms 

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

• The global clinical trial imaging market size was estimated at USD 1.14 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.60% from 2024 to 2030.

• The global patient monitoring devices market size was valued at USD 51.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.7% from 2023 to 2030.

Urinalysis Market Segmentation

Grand View Research has segmented the global urinalysis market based on product, application, end-use, and region:

Urinalysis Product Outlook (Revenue, USD Million, 2018 - 2030)
• Instrument
o Biochemical urine analyzers
o Automated biochemical analyzers
o Semi-automated biochemical analyzers
o Automated urine sediment analyzers
o Microscopic urine analyzers
o Flow-cytometric urine analyzers
o Point-of-care urine analyzers
• Consumables
o Dipsticks
o Reagents
o Disposables
o Pregnancy and fertility kits

Urinalysis Application Outlook (Revenue, USD Million, 2018 - 2030)
• Disease Screening
o UTIs
o Diabetes
o Kidney disease
o Hypertension
o Liver disease
o Others
• Pregnancy and Fertility Testing

Urinalysis End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Clinical Laboratories
• Home Care
• Research and Academics
• Others

Urinalysis Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East and Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

Order a free sample PDF of the Urinalysis Market Intelligence Study, published by Grand View Research.